First Trimester Antenatal Screening

Author(s):  
T.K. Lau
2005 ◽  
Vol 61 (9) ◽  
pp. 1983-1992 ◽  
Author(s):  
Clare Williams ◽  
Jane Sandall ◽  
Gillian Lewando-Hundt ◽  
Bob Heyman ◽  
Kevin Spencer ◽  
...  

Midwifery ◽  
2017 ◽  
Vol 47 ◽  
pp. 15-21 ◽  
Author(s):  
Maarit Nykänen ◽  
Katri Vehviläinen-Julkunen ◽  
Reija Klemetti

2018 ◽  
Vol 25 (3) ◽  
pp. 114-118
Author(s):  
Drahomira Springer ◽  
Jaroslav Loucky ◽  
Pavel Tesner ◽  
David Cutka ◽  
David Stejskal ◽  
...  

Objective In the Czech Republic, over 97% of all pregnant women undergo some type of antenatal screening for Down’s syndrome. In about 95% of cases with a confirmed fetal chromosomal abnormality, the pregnancy is terminated. The most commonly used test is the first trimester combined test. We investigated the impact of implementing an integrated sequential test to improve the detection of Down’s syndrome pregnancies. Methods Data on the incidence of congenital defects, number of births, and affected pregnancies terminated are recorded in the National Registry of Congenital Anomalies. Anonymous data on cases of Down’s syndrome diagnosed antenatally or postnatally between 2010 and 2015 in one of the large antenatal care centers were analyzed. Results There were 600 diagnoses of Down’s syndrome (5.7 per 1000 births), 90% of which were made antenatally. Of antenatally detected cases, 80% were indicated for diagnostic procedure by multimarker screening results. In the multimarker screen positive group, 75% cases were first trimester positive and 25% second trimester positive (most of these had positive integrated test results). Among Down’s syndrome cases indicated for antenatal diagnosis by multimarker screening results 6.25% (n = 26) were first trimester negative, and became positive after integration with the second trimester screening results. Conclusions Results from five major Czech antenatal centers confirm that an integrated sequential test would detect 80–85% of Down’s syndrome fetuses in the first trimester and at least an extra 5–10% of Down’s syndrome pregnancies in the second trimester of pregnancy. These are important data that should be considered in implementing the national antenatal screening program.


2008 ◽  
Vol 16 (3) ◽  
pp. 156-159 ◽  
Author(s):  
Gillian Lewando Hundt ◽  
J Sandall ◽  
K Spencer ◽  
B Heyman ◽  
C Williams ◽  
...  

2018 ◽  
Vol 25 (4) ◽  
pp. 169-173
Author(s):  
Jonathan P Bestwick ◽  
Wayne J Huttly ◽  
Nicholas J Wald

Objective To assess whether the accuracy of risk estimation in antenatal screening for trisomy 18 using the Combined test can be improved by revising the truncation limits of two serum markers. Methods In an audit of data from 420 trisomy 18 and 573,754 unaffected singleton pregnancies screened at the Wolfson Institute of Preventive Medicine, London (March 2003 to June 2017), the accuracy of risk estimation was assessed by inspection of a validation plot (the median predicted late first trimester Combined test risk plotted against observed prevalence within categories of predicted risk estimates). Using validation and probability plots, we assessed whether the revised pregnancy-associated plasma protein A (PAPP-A) and free β-human chorionic gonadotrophin (free β-hCG) truncation limits led to more accurate risk estimation and improved screening performance. Results With the lower truncation limits currently used for PAPP-A and free β-hCG (0.15 and 0.30 multiples of the median [MoM], respectively), risk was underestimated. Revised lower truncation limits of 0.05 MoM for both PAPP-A and free β-hCG led to greater accuracy, with an increase in the number of trisomy 18 pregnancies detected (from 85.4% to 90.2%) for a small increase in the false-positive rate (from 0.20% to 0.29%) at a 1 in 100 late first trimester risk cut-off. Conclusion The revised truncation limits for PAPP-A and free β-hCG increase the accuracy of trisomy 18 risk estimation and improve screening performance using the Combined test. Validation and probability plots are useful in setting screening marker truncation limits.


Ultrasound ◽  
2005 ◽  
Vol 13 (4) ◽  
pp. 226-230 ◽  
Author(s):  
B. Stenberg ◽  
R. Lee ◽  
A. M. Dixon

This review is based on a third-year undergraduate project undertaken by Ben Stenberg and submitted as part of a BSc (Honours) Radiography award at the University of Teesside. The project and this report reviews the concept of antenatal screening for Down's syndrome, it explores the role of ultrasound and other available tests, and considers sensitivities and potential for errors in a first trimester screening service. The review employs library based literature review methodology and its limitations reflect the size and scope of projects performed within undergraduate research regulations.


Sign in / Sign up

Export Citation Format

Share Document